HIVMA Names Colleen Kelley, MD, MPH, FIDSA, Chair of the Board

The HIV Medicine Association is pleased to announce the election of Colleen Kelley, MD, MPH, FIDSA, as the new chair of its Board of Directors. HIVMA is dedicated to addressing health disparities and health inequities in its mission to end the HIV epidemic. The Association elected a new vice chair and named three new directors.  

Dr. Kelley is a professor at the Emory University School of Medicine in Atlanta, Georgia. Her research focuses on biomedical HIV prevention, HIV susceptibility in sexual and gender minorities, disparities in HIV incidence and how people’s lived experiences affect their susceptibility to sexually transmitted infections. Dr. Kelley provides clinical care at the Grady Health System Ponce De Leon Center and Grady Memorial Hospital.

“We will only achieve an end to the HIV epidemic by tackling the root causes of inequity in health care access and outcomes,” said Dr. Kelley. “As historically marginalized communities continue to face increased vulnerability to acquiring HIV, I am committed as chair to working with my fellow Board members to advance HIVMA’s mission to increase access to equitable HIV prevention and care services for everyone who needs it.”

Philip Bolduc, MD, was elected to serve as vice chair. He is an associate professor of family medicine and community health at the University of Massachusetts Chan Medical School and centers his academic work on promoting primary care-based HIV and hepatitis care. Dr. Bolduc serves as director of special populations at the Family Health Center of Worcester, Massachusetts, where he provides relationship-based care to diverse and historically excluded populations and brings together multispecialty teams to provide holistic, comprehensive care.

The three newly elected HIIVMA Board members are:

• Ellen Eaton, MD, FIDSA, is an associate professor in the Department of Medicine and Division of Infectious Diseases at the University of Alabama at Birmingham. In her research, Dr. Eaton focuses on how social determinants of health, addiction and mass incarceration work against HIV prevention, and explores methods to advance the development of addiction treatment for patients. She serves as the director of the Outpatient-Based Addiction Treatment Clinic at the 1917 Clinic in Birmingham, Alabama. Dr. Eaton’s additional background in public health has given her insights into syndemics, health equity and issues affecting rural communities. 
  
  
• Nwora Lance Okeke, MD, MPH, is an associate professor of medicine and Population Health Sciences at the Duke University School of Medicine in Durham, North Carolina. He leads a research program focused on implementation science-informed approaches to optimizing HIV health services utilization from HIV prevention to the comorbid chronic disease management.  Dr. Okeke is an associate director of the Duke Center for AIDS Research, and vice chief for Diversity, Equity and Inclusion for the Duke Division of Infectious Diseases. He is also the founding director of Evidence2Practice, a program that promotes careers in HIV to students at Historically Black Colleges and Universities. For this work, he received the HIVMA Innovator Award in 2023. 
  
  
• Hussein Safa, MD, is an assistant professor with the Department of Family and Social Medicine in the Bronx for their NYC Homeless Healthcare Fellowship and an affiliated clinician at the Jefferson Einstein Philadelphia Hospital who provides gender affirming primary care for LGBTQ patients, HIV primary care, and sex-positive PrEP services. He is interested in advancing health equity among racial, gender and sexually diverse groups, especially to ensure that policy and innovation surrounding HIV treatment accounts for their experiences. Dr. Safa completed a residency in family and social medicine at Montefiore Medical Center in New York City, where he studied the practice of comprehensive HIV care.

Joining Dr. Kelley and Dr. Bolduc on the Executive Committee of the HIVMA Board of Directors will be Immediate Past Chair Allison Agwu, MD, ScM, FIDSA, Johns Hopkins University, Baltimore, Maryland; Chair-Elect Anna K. Person, MD, FIDSA, Vanderbilt University, Nashville, Tennessee; and the HIVMA Representative to the IDSA Board Rajesh T. Gandhi, MD, FIDSA, Massachusetts General Hospital, Boston, Massachusetts. 

The following members will continue their service on the HIVMA Board:

• Nicholas Allen, DNP, Washington Department of Corrections
• Joseph S. Cervia, MD, MBA, FACP, FAAP, FIDSA, FPIDS, AAHIVS, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
• Joseph Cherabie, MD, MSc, Washington University in St. Louis
• Nada Fadul, MD, FIDSA, University of Nebraska Medical Center
• Kathleen Jacobson, MD, California Department of Health
• Carlos D. Malvestutto, MD, MPH, Ohio State University Wexner Medical Center
• Darrell McBride, DO, Geisinger Commonwealth School of Medicine
• Elizabeth Sherman, PharmD, Memorial Healthcare System
• Hansel Emory Tookes III, MD, MPH, University of Miami Miller School of Medicine
• Virginia Triant, MD, MPH, FIDSA, Massachusetts General Hospital

 

About the Infectious Diseases Society of America
IDSA is a leader on issues of importance to ID professionals, including education and training, policy and advocacy, setting guidelines for patient care and developing resources for clinical practice. It remains at the forefront of global health issues such as COVID-19, antimicrobial resistance and HIV/AIDS. Housed within IDSA is the HIV Medicine Association, which represents medical providers and researchers working on the front lines of HIV. More than 13,000 IDSA and HIVMA members work across the United States and in nearly 100 other countries on six different continents. For more information visit idsociety.org and hivma.org. Follow IDSA on Facebook and X and follow HIMVA on Facebook and X.